10-Q

Company

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Filed

January 9, 2019

Period of Report

November 30, 2018

Accession Number

0001144204-19-001220

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →